tiprankstipranks
Advertisement
Advertisement

IPHA Stock Latest News

Innate Pharma price target raised to $9 from $8 at BTIG
The FlyInnate Pharma price target raised to $9 from $8 at BTIG
19d ago
IPHA
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
PremiumThe Fly
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
25d ago
IPHA
Innate Pharma upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Innate Pharma upgraded to Outperform from Market Perform at Leerink
25d ago
IPHA
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
PremiumThe Fly
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
26d ago
IPHA
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
PremiumThe Fly
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
26d ago
IPHA
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
PremiumThe FlyInnate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
26d ago
IPHA
Innate Pharma completes enrollment in dose escalation of IPH4502 study
Premium
The Fly
Innate Pharma completes enrollment in dose escalation of IPH4502 study
2M ago
IPHA
Innate Pharma: Buy Rating Reaffirmed on Pipeline Momentum and De‑Risking Catalysts; $8 Price Target Unchanged
Premium
Ratings
Innate Pharma: Buy Rating Reaffirmed on Pipeline Momentum and De‑Risking Catalysts; $8 Price Target Unchanged
4M ago
IPHA
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
PremiumRatings
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
5M ago
IPHA
Innate Pharma assumed with a Buy at BTIG
PremiumThe Fly
Innate Pharma assumed with a Buy at BTIG
6M ago
IPHA
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
PremiumRatings
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
6M ago
IPHA
Innate Pharma announces FDA clearance to proceed with TELLOMAK 3 trial
PremiumThe Fly
Innate Pharma announces FDA clearance to proceed with TELLOMAK 3 trial
10M ago
IPHA
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyInnate Pharma upgraded to Buy from Neutral at H.C. Wainwright
10M ago
IPHA
Innate Pharma initiated with a Buy at Lucid Capital
Premium
The Fly
Innate Pharma initiated with a Buy at Lucid Capital
11M ago
IPHA
Innate Pharma management to meet with BTIG
Premium
The Fly
Innate Pharma management to meet with BTIG
11M ago
IPHA
Innate Pharma management to meet with BTIG
PremiumThe Fly
Innate Pharma management to meet with BTIG
11M ago
IPHA
Target initiated, Nike upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target initiated, Nike upgraded: Wall Street’s top analyst calls
12M ago
DG
HD
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
12M ago
IPHA
Innate Pharma SA Reports First Half 2025 Financial Results
PremiumCompany Announcements
Innate Pharma SA Reports First Half 2025 Financial Results
12M ago
IPHA
Innate Pharma’s Strategic Shift and Financial Challenges Lead to Hold Rating
PremiumRatingsInnate Pharma’s Strategic Shift and Financial Challenges Lead to Hold Rating
12M ago
IPHA
Innate Pharma downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Innate Pharma downgraded to Market Perform from Outperform at Leerink
12M ago
IPHA
Innate Pharma initiated with a Buy at BTIG
Premium
The Fly
Innate Pharma initiated with a Buy at BTIG
1y ago
IPHA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >